Cargando…

Advances in Osteosarcoma

PURPOSE OF REVIEW: This article gives a brief overview of the most recent developments in osteosarcoma treatment, including targeting of signaling pathways, immune checkpoint inhibitors, drug delivery strategies as single or combined approaches, and the identification of new therapeutic targets to f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Panez-Toro, Isidora, Muñoz-García, Javier, Vargas-Franco, Jorge W., Renodon-Cornière, Axelle, Heymann, Marie-Françoise, Lézot, Frédéric, Heymann, Dominique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393907/ https://www.ncbi.nlm.nih.gov/pubmed/37329384 http://dx.doi.org/10.1007/s11914-023-00803-9

Ejemplares similares

In vitro three-dimensional cell cultures for bone sarcomas
por: Munoz-Garcia, Javier, et al.
Publicado: (2021)

Inhibiting Endothelin Receptors with Macitentan Strengthens the Bone Protective Action of RANKL Inhibition and Reduces Metastatic Dissemination in Osteosarcoma
por: Muñoz-Garcia, Javier, et al.
Publicado: (2022)

The Intrinsic and Extrinsic Implications of RANKL/RANK Signaling in Osteosarcoma: From Tumor Initiation to Lung Metastases
por: Navet, Benjamin, et al.
Publicado: (2018)

RANK–RANKL signalling in cancer
por: Renema, Nathalie, et al.
Publicado: (2016)

Biological evidence of cancer stem-like cells and recurrent disease in osteosarcoma
por: Jubelin, Camille, et al.
Publicado: (2022)

The twin cytokines interleukin-34 and CSF-1: masterful conductors of macrophage homeostasis
por: Muñoz-Garcia, Javier, et al.
Publicado: (2021)

Lipopolysaccharide-binding protein expression is associated to the metastatic status of osteosarcoma patients
por: Heymann, Clément J.F., et al.
Publicado: (2022)

Characterization of Affitin proteolytic digestion in biorelevant media and improvement of their stabilities via protein engineering
por: Loussouarn, Aurélie, et al.
Publicado: (2020)

Current Therapeutic Strategies and Novel Approaches in Osteosarcoma
por: Ando, Kosei, et al.
Publicado: (2013)

Technical report: liquid overlay technique allows the generation of homogeneous osteosarcoma, glioblastoma, lung and prostate adenocarcinoma spheroids that can be used for drug cytotoxicity measurements
por: Jubelin, Camille, et al.
Publicado: (2023)

ICG-001, an Inhibitor of the β-Catenin and cAMP Response Element-Binding Protein Dependent Gene Transcription, Decreases Proliferation but Enhances Migration of Osteosarcoma Cells
por: Danieau, Geoffroy, et al.
Publicado: (2021)

Safety Concern between Autologous Fat Graft, Mesenchymal Stem Cell and Osteosarcoma Recurrence
por: Perrot, Pierre, et al.
Publicado: (2010)

The archaeal “7 kDa DNA-binding” proteins: extended characterization of an old gifted family
por: Kalichuk, Valentina, et al.
Publicado: (2016)

Dysregulation of macrophage polarization is associated with the metastatic process in osteosarcoma
por: Dumars, Clotilde, et al.
Publicado: (2016)

Maternal RANKL Reduces the Osteopetrotic Phenotype of Null Mutant Mouse Pups
por: Navet, Benjamin, et al.
Publicado: (2018)

Isolation of circulating tumor cells in a preclinical model of osteosarcoma: Effect of chemotherapy
por: Chalopin, Antoine, et al.
Publicado: (2018)

Ca(2+) improves organization of single-stranded DNA bases in human Rad51 filament, explaining stimulatory effect on gene recombination
por: Fornander, Louise H., et al.
Publicado: (2012)

New Phosphorylation Sites of Rad51 by c-Met Modulates Presynaptic Filament Stability
por: Chabot, Thomas, et al.
Publicado: (2019)

Molecular Alterations Associated with Osteosarcoma Development
por: Ando, Kosei, et al.
Publicado: (2012)

Imatinib Mesylate Exerts Anti-Proliferative Effects on Osteosarcoma Cells and Inhibits the Tumour Growth in Immunocompetent Murine Models
por: Gobin, Bérengère, et al.
Publicado: (2014)

Probing Rad51-DNA interactions by changing DNA twist
por: Atwell, Scott, et al.
Publicado: (2012)

Circulating Tumor Cells as a Tool for Assessing Tumor Heterogeneity
por: Tellez-Gabriel, Marta, et al.
Publicado: (2019)

Small animal models for the study of bone sarcoma pathogenesis:characteristics, therapeutic interests and limitations
por: Jacques, Camille, et al.
Publicado: (2018)

Design of Potent Inhibitors of Human RAD51 Recombinase Based on BRC Motifs of BRCA2 Protein: Modeling and Experimental Validation of a Chimera Peptide
por: Nomme, Julian, et al.
Publicado: (2010)

Swi5-Sfr1 protein stimulates Rad51-mediated DNA strand exchange reaction through organization of DNA bases in the presynaptic filament
por: Fornander, Louise H., et al.
Publicado: (2014)

Origins of Alterations to Rankl Null Mutant Mouse Dental Root Development
por: Gama, Andrea, et al.
Publicado: (2020)

Three-dimensional in vitro culture models in oncology research
por: Jubelin, Camille, et al.
Publicado: (2022)

Primary Retention of Molars and RANKL Signaling Alteration during Craniofacial Growth
por: Gama, Andrea, et al.
Publicado: (2020)

Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastases
por: Lamora, Audrey, et al.
Publicado: (2015)

Receptor tyrosine kinases: Characterisation, mechanism of action and therapeutic interests for bone cancers
por: Ségaliny, Aude I., et al.
Publicado: (2015)

Tumour Heterogeneity: The Key Advantages of Single-Cell Analysis
por: Tellez-Gabriel, Marta, et al.
Publicado: (2016)

Biology of Bone Sarcomas and New Therapeutic Developments
por: Brown, Hannah K., et al.
Publicado: (2017)

Clusterin inhibition using OGX-011 synergistically enhances zoledronic acid activity in osteosarcoma
por: Lamoureux, Francois, et al.
Publicado: (2014)

Bone Tumor Environment as a Potential Therapeutic Target in Ewing Sarcoma
por: Redini, Françoise, et al.
Publicado: (2015)

Circulating Tumor Cell-Derived Pre-Clinical Models for Personalized Medicine
por: Tellez-Gabriel, Marta, et al.
Publicado: (2018)

The Challenges of Detecting Circulating Tumor Cells in Sarcoma
por: Tellez-Gabriel, Marta, et al.
Publicado: (2016)

Jaw osteosarcoma models in mice: first description
por: Bertin, Hélios, et al.
Publicado: (2019)

Bidirectional regulation of bone formation by exogenous and osteosarcoma-derived Sema3A
por: de Ridder, Daniëlle, et al.
Publicado: (2018)

Osteoprotegerin inhibits bone resorption and prevents tumor development in a xenogenic model of Ewing's sarcoma by inhibiting RANKL
por: Picarda, Gaëlle, et al.
Publicado: (2013)

Anti-RANKL therapy for bone tumours: Basic, pre-clinical and clinical evidences
por: Heymann, Dominique
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_n66hm7aknp2aq9v3c9a6ssq231